Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Kane · SciRah

Researcher profile · Semantic Scholar

R. Kane

Share profile

R. Kane — researcher profile on SciRah

h-index: 26
Works: 64
Citations: 4,774

Most-cited papers

Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy.
R. Kane, Peter F. Bross, A. Farrell, R. Pazdur
2003The Oncologist672 citations Open access
Semantic Scholar
Sorafenib for the Treatment of Advanced Renal Cell Carcinoma
R. Kane, A. Farrell, H. Saber, Sheng-Hui Tang +10 more
2006Clinical Cancer Research462 citations Open access
Semantic Scholar
Approval Summary for Bortezomib for Injection in the Treatment of Multiple Myeloma
Peter F. Bross, R. Kane, A. Farrell, S. Abraham +17 more
2004Clinical Cancer Research342 citations Open access
Semantic Scholar
FDA Approval: Blinatumomab
D. Przepiorka, Chia-Wen Ko, A. Deisseroth, C. Yancey +14 more
2015Clinical Cancer Research334 citations Open access
Semantic Scholar
United States Food and Drug Administration Approval Summary: Bortezomib for the Treatment of Progressive Multiple Myeloma after One Prior Therapy
R. Kane, A. Farrell, R. Sridhara, R. Pazdur
2006Clinical Cancer Research334 citations Open access
Semantic Scholar
FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma
Hyon-Zu Lee, V. Kwitkowski, P. D. Del Valle, M. Ricci +15 more
2015Clinical Cancer Research294 citations Open access
Semantic Scholar
Interpretability of Cancer Clinical Trial Results Using Restricted Mean Survival Time as an Alternative to the Hazard Ratio
K. Pak, H. Uno, D. H. Kim, L. Tian +5 more
2017JAMA Oncology259 citations Open access
Semantic Scholar
Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products.
Cunlin Wang, D. Graham, R. Kane, Di-Qiong Xie +12 more
2015Journal of the American Medical Association (JAMA)211 citations Open access
Semantic Scholar
U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma
T. Herndon, A. Deisseroth, E. Kaminskas, R. Kane +15 more
2013Clinical Cancer Research208 citations Open access
Semantic Scholar
U.S. Food and Drug Administration Approval Summary: Brentuximab Vedotin for the Treatment of Relapsed Hodgkin Lymphoma or Relapsed Systemic Anaplastic Large-Cell Lymphoma
R. A. de Claro, Karen M. McGinn, V. Kwitkowski, J. Bullock +17 more
2012Clinical Cancer Research194 citations Open access
Semantic Scholar
Bortezomib for the Treatment of Mantle Cell Lymphoma
R. Kane, R. Dagher, A. Farrell, Chia-Wen Ko +3 more
2007Clinical Cancer Research179 citations Open access
Semantic Scholar
FDA Approval: Idelalisib Monotherapy for the Treatment of Patients with Follicular Lymphoma and Small Lymphocytic Lymphoma
Barry W. Miller, D. Przepiorka, R. A. de Claro, Kyung Lee +16 more
2015Clinical Cancer Research141 citations
Semantic Scholar
Sorafenib for the treatment of unresectable hepatocellular carcinoma.
R. Kane, A. Farrell, R. Madabushi, B. Booth +4 more
2009The Oncologist135 citations Open access
Semantic Scholar
FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia
R. A. de Claro, Karen M. McGinn, N. Verdun, Shwu-Luan Lee +17 more
2015Clinical Cancer Research127 citations Open access
Semantic Scholar
Low dose elective brain irradiation in small cell carcinoma of the lung.
D. Beiler, R. Kane, A. Bernath, M. Cashdollar
1978International Journal of Radiation Oncology, Biology, Physics86 citations
Semantic Scholar
U.S. Food and Drug Administration approval summary: omacetaxine mepesuccinate as treatment for chronic myeloid leukemia.
F. Alvandi, V. Kwitkowski, Chia-Wen Ko, Mark Rothmann +12 more
2014The Oncologist85 citations Open access
Semantic Scholar
Dexrazoxane (Totect): FDA review and approval for the treatment of accidental extravasation following intravenous anthracycline chemotherapy.
R. Kane, W. D. Mcguinn, R. Dagher, R. Justice +1 more
2008The Oncologist79 citations Open access
Semantic Scholar
Adriamycin therapy in American patients with hepatocellular carcinoma.
D. Ihde, R. Kane, M. Cohen, K. Mcintire +1 more
1977Cancer treatment reports64 citations
Semantic Scholar
Superior vena caval obstruction due to small-cell anaplastic lung carcinoma. Response to chemotherapy.
R. Kane, M. Cohen
1976Journal of the American Medical Association (JAMA)56 citations
Semantic Scholar
Fiberoptic Bronchoscopy and Culture of Bacteria from the Lower Respiratory Tract
B. Fossieck, R. H. Parker, M. Cohen, R. Kane
197754 citations
Semantic Scholar
Absence of bacteremia after fiberoptic bronchoscopy.
R. Kane, Martin H. Cohen, Byron E. Fossieck, Anita V. Tvardzik
1975American Review of Respiratory Disease42 citations
Semantic Scholar
Generic oncology drugs: are they all safe?
Y. T. Yang, S. Nagai, Brian K. Chen, Z. Qureshi +13 more
2016The Lancet Oncology40 citations
Semantic Scholar
U.S. Food and Drug Administration Approval: Obinutuzumab in Combination with Chlorambucil for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia
Hyon-Zu Lee, Barry W. Miller, V. Kwitkowski, Stacey Ricci +15 more
2014Clinical Cancer Research38 citations Open access
Semantic Scholar
Association Between Changes in CMS Reimbursement Policy and Drug Labels for Erythrocyte-Stimulating Agents With Outcomes for Older Patients Undergoing Hemodialysis Covered by Fee-for-Service Medicare.
Cunlin Wang, R. Kane, Mark S. Levenson, Jeffrey A. Kelman +14 more
2016JAMA Internal Medicine30 citations Open access
Semantic Scholar
Prevalence of pain and analgesic use in men with metastatic prostate cancer using a patient-reported outcome measure.
K. Autio, A. Bennett, X. Jia, M. Fruscione +10 more
2013Journal of Oncology Practice30 citations Open access
Semantic Scholar
Phase I-II evaluation of emetine (NSC-33669) in the treatment of epidermoid bronchogenic carcinoma.
R. Kane, M. Cohen, L. Broder, M. Bull +2 more
1975Cancer chemotherapy reports28 citations
Semantic Scholar
Cardiac imaging approaches to evaluate drug-induced myocardial dysfunction
J. Christian, John K. Finkle, B. Ky, P. Douglas +19 more
2012American Heart Journal26 citations Open access
Semantic Scholar
Pain palliation measurement in cancer clinical trials: The US Food and Drug Administration perspective
E. Basch, Ann Marie Trentacosti, L. Burke, V. Kwitkowski +8 more
2014Cancer25 citations
Semantic Scholar
Melanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR)
R. Sabol, V. Noxon, O. Sartor, J. Berger +11 more
2017Cancer Medicine24 citations Open access
Semantic Scholar
Iron deficiency: what are the future trends in diagnostics and therapeutics?
C. Brugnara, J. Adamson, M. Auerbach, R. Kane +2 more
2013Clinical Chemistry24 citations
Semantic Scholar
Phase II trial of cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II) combination chemotherapy in advanced ovarian carcinoma.
R. Kane, H. Harvey, T. Andrews, A. Bernath +8 more
1979Cancer treatment reports22 citations
Semantic Scholar
A possible association between fetal/neonatal exposure to radiofrequency electromagnetic radiation and the increased incidence of autism spectrum disorders (ASD).
R. Kane
2004Medical Hypotheses20 citations
Semantic Scholar
Caution in making inferences from FDA's Adverse Event Reporting System.
M. Auerbach, R. Kane
2012American Journal of Health-System Pharmacy17 citations
Semantic Scholar
Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada.
Brian J. Chen, S. Nagai, J. Armitage, Bartlett J. Witherspoon +20 more
2019The Oncologist16 citations Open access
Semantic Scholar
The clinical significance of statistical significance.
R. Kane
2008The Oncologist14 citations
Semantic Scholar
Cellular telephones and brain tumors.
R. Kane
2001New England Journal of Medicine12 citations
Semantic Scholar
Case reports. Diffuse skeletal and hepatic hemangiomatosis.
R. Kane, A. Newman
1973California medicine9 citations
Semantic Scholar
Intravenous iron replacement with sodium ferric gluconate complex in sucrose for iron deficiency anemia in adults.
R. Kane
2003Current Therapeutic Research7 citations Open access
Semantic Scholar
Gemtuzumab ozogamicin.
D. Przepiorka, A. Deisseroth, R. Kane, E. Kaminskas +2 more
2013Journal of Clinical Oncology6 citations
Semantic Scholar
Toxicity of laromustine plus high-dose cytarabine in patients with relapsed acute myeloid leukemia.
A. Deisseroth, A. Farrell, R. Justice, R. Kane +4 more
2010Blood5 citations
Semantic Scholar
Treatment of advanced colorectal cancer with methyl-CCNU plus 5-day 5-fluorouracil infusion.
R. Kane, M. Cashdollar, A. Bernath
1978Cancer treatment reports5 citations
Semantic Scholar
Re: When you look matters: the effect of assessment schedule on progression-free survival.
R. Kane
2007Journal of the National Cancer Institute4 citations Open access
Semantic Scholar
Strategies to overcome barriers to accrual (BtA) to NCI-sponsored clinical trials: A project of the NCI-Myeloma Steering Committee Accrual Working Group (NCI-MYSC AWG).
M. Weiss, M. Gertz, R. Little, V. Rajkumar +15 more
20133 citations
Semantic Scholar
Identification of Significant Barriers to Accrual (BtA) to NCI Sponsored Multiple Myeloma – Clinical Trials (MM-CT): A Step towards Improving Accrual to Clinical Trials.
M. Weiss, S. Jacobus, R. Abonour, K. Anderson +16 more
20123 citations
Semantic Scholar
Comparative effectiveness and health care spending.
R. Kane
2010New England Journal of Medicine3 citations Open access
Semantic Scholar
Phase II trial of streptozotocin for small cel anaplastic carcinoma of the lung.
R. Kane, A. Bernath, M. Cashdollar
1978Cancer treatment reports3 citations
Semantic Scholar
Diffuse Skeletal and Hepatic Hemangiomatosis
R. Kane, A. Newman, San Francisco
20061 citations
Semantic Scholar
Poor ESA Responders As Defined By Week 4 Hemoglobin Response Have Greater ESA Dosing but Worse Cardiovascular Outcomes in Patients with Anemia of Chronic Kidney Disease (CKD) Not on Dialysis
R. Kane, Qing Xu, R. Sridhara, J. Earp
20140 citations
Semantic Scholar
Re: potential pitfalls of crossover and thoughts on iniparib in triple-negative breast cancer.
R. Kane
2012Journal of the National Cancer Institute0 citations Open access
Semantic Scholar
A Possible Association Between Fetal / neonatal Exposure to Radiofrequency Electromagnetic Radiation and the Increased Incidence of Autism Spectrum Disorders
R. Kane
20110 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Farrell×16
Invite
A. Farrell — researcher profile on SciRah
R. Pazdur×16
Invite
R. Pazdur — researcher profile on SciRah
R. Justice×10
Invite
R. Justice — researcher profile on SciRah
E. Kaminskas×8
Invite
E. Kaminskas — researcher profile on SciRah

×7

Invite

H. Saber — researcher profile on SciRah

Invite

R. Sridhara — researcher profile on SciRah

Invite

J. Bullock — researcher profile on SciRah

V. Kwitkowski×5

Invite

V. Kwitkowski — researcher profile on SciRah

Invite

J. Brown — researcher profile on SciRah

Invite

Chia-Wen Ko — researcher profile on SciRah

A. Deisseroth×4

Invite

A. Deisseroth — researcher profile on SciRah

Invite

N. Mehrotra — researcher profile on SciRah